NL
ABBV icon

NorthAvenue LLC’s AbbVie ABBV Stock Holding History

NorthAvenue LLC’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.7K Hold
118
– – 0.02% 97
2026
Q1 		$25.7K Hold
118
– – 0.02% 92
2025
Q4 		$27K Buy
+118
New +$26.9K 0.02% 93

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

NorthAvenue LLC's ABBV Position: Q2 2026 in Review

NorthAvenue LLC held its AbbVie (ABBV) position steady in Q2 2026 at 118 shares worth $29.7K. The position accounts for 0.02% of the portfolio, ranked #97.

NorthAvenue LLC first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 1,933 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • NorthAvenue LLC held 118 shares of AbbVie worth $29.7K as of Q2 2026.
  • NorthAvenue LLC left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.02% of NorthAvenue LLC's portfolio in Q2 2026, its #97 holding.
  • NorthAvenue LLC first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 1,933 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on NorthAvenue LLC's 13F filing for Q2 2026, filed 21 Jul 2026.